After-market Movers For April 22 (T, AMGN, YUM, GILD, SWKS, SMCI, ILMN, SKX, CREE, ISRG)

(RTTNews) - Gainers:

Yum! Brands, Inc. (YUM) rose 4 percent to $80.51. The company's first quarter earnings were higher than in the year-ago quarter and its adjusted earnings per share topped market view. Revenues increased 7 percent, but were below the consensus estimate. China Division system sales increased 17 percent, boosted by 7 percent unit growth and 9 percent same-store sales growth. Further, the company expects to achieve EPS growth of at least 20 percent in 2014.

Gilead Sciences Inc. (GILD) gained over 2 percent to $74.60 as the company's first quarter results topped analysts' expectations by a wide margin. Antiviral product sales doubled largely due to sales of Sovaldi, which launched in December 2013, and increases in sales of Stribild and Complera/Eviplera. The company also reiterated its full year 2014 guidance.

Skyworks Solutions Inc. (SWKS) surged 9 percent to $41.40. The company's second quarter results came above Street view and also guided third quarter results above analysts' projections.

Super Micro Computer, Inc. (SMCI) jumped 17 percent to $22.15. The company's third quarter results surpassed Street view and also provided a positive outlook for the fourth quarter.

Illumina Inc. (ILMN) was up 8 percent to $160.30. The company swung to a profit in its first quarter and its adjusted earnings per share topped Street view. Revenues increased 27 percent and came in above the consensus estimate. The company also raised its fiscal 2014 adjusted earnings outlook.

Skechers USA Inc. (SKX) surged 12 percent to $41.25 as its first quarter results blowed past the analysts' expectations. The company attributed the 21 percent growth in sales to double-digit increases in its domestic and international wholesale business, as well as increases in its worldwide company-owned retail business.

Decliners:

AT&T, Inc. (T) fell 2 percent to $35.53. The company's first quarter adjusted earnings per share and revenues topped Wall Street view. The company raised its full year 2014 revenue growth forecast to 4 percent or greater and expects adjusted earnings per share growth in the mid-single digit range including Leap operational pressure.

Amgen Inc. (AMGN) declined 2 percent to $116.75. The company's first quarter profit declined from the year-ago quarter and its adjusted earnings per share missed Street view. Revenues rose 7 percent, but came in below the consensus estimate. At the same time, the company backed its fiscal year 2014 guidance.

Cree, Inc. (CREE) was down 7 percent to $53.90. The company's third quarter earnings per share managed to come above Street view, while revenues missed the consensus estimate. The company forecast the top end of its adjusted earnings per share outlook range to meet the average analysts' estimate.

Intuitive Surgical, Inc. (ISRG) declined 7 percent to $393.00. The company's first quarter profit and revenues plunged from the year-ago quarter and also fell short of analysts' expectations.